Imagine a scenario where hospitals, in a bid to cut costs, prevent cancer units from hiring the very doctors needed to diagnose and treat patients. Sounds alarming, doesn’t it? This is the harsh reality facing the NHS, and doctors are sounding the alarm, calling these hiring bans shortsighted and downright dangerous.
Here’s the shocking truth: In 2025, a staggering 50% of the UK’s 60 specialist cancer treatment centers were slapped with a recruitment freeze for clinical oncologists. That’s more than double the 23% seen just a year earlier. But it doesn’t stop there. Over a third (36%) of the 160 radiology departments—the teams responsible for performing and analyzing scans—faced similar bans in 2025, up from 19% in 2024. These figures, provided by 138 of the UK’s 160 radiology units, paint a grim picture.
And this is the part most people miss: Smaller cancer centers and radiology departments, often serving rural communities, are disproportionately affected. Across the UK, 60% of cancer centers in rural or deprived areas faced recruitment freezes, compared to 48% in urban and wealthier areas. This disparity raises serious questions about equitable access to care.
The Royal College of Radiologists (RCR), which compiled these statistics, warns that these staffing freezes could lead to dangerous delays in cancer diagnosis and treatment. Dr. Stephen Harden, the RCR’s president, didn’t hold back, labeling the bans as “shortsighted” and detrimental to patient care, staff morale, and long-term costs. He emphasized that such delays can have tragic consequences, especially for cancer patients, where each month’s delay increases the risk of death by approximately 10%.
But here’s where it gets controversial: These hiring bans are part of an NHS financial “reset” ordered by Sir Jim Mackey, CEO of NHS England, to tackle a £6.6 billion overspend in 2025-26. While cost-cutting is necessary, critics argue that slashing recruitment in cancer care is a false economy. In fact, the NHS spent a record £325 million in 2024 on locum staff and private firms—some overseas—to fill gaps left by understaffed radiology departments.
The irony? These cuts come just as the government unveils its ambitious plan to improve cancer care in England, aiming to increase the number of cancer doctors in underserved rural and coastal areas. Yet, the very departments tasked with implementing this plan are being handcuffed by hiring bans.
Cancer Research UK (CRUK) estimates that by 2029, the NHS in England will need 16,000 more staff in cancer services, including 8,300 diagnostic radiographers, 4,600 radiologists, and 790 medical and clinical oncologists. The government’s new plan acknowledges this, promising to grow the cancer workforce and leverage technology, such as AI, to enhance productivity. But without addressing the immediate staffing crisis, these goals risk remaining on paper.
Here’s a thought-provoking question for you: Is it ethical to prioritize short-term financial savings over the lives of cancer patients? And if not, what steps should the NHS and government take to reverse these hiring bans and ensure cancer units are fully staffed?
Dr. Harden warns that unless this issue is tackled head-on, persistent understaffing will undermine efforts to improve early diagnosis and treatment. He urges an end to the hiring bans, stressing that with cancer diagnoses set to rise, the NHS will need these skilled clinicians more than ever. The UK, he adds, needs nearly 2,000 more radiologists and 200 more clinical oncologists just to meet current demand.
Holly Norman, from CRUK, echoes this sentiment, emphasizing that radiologists and oncologists are vital for swift diagnosis and treatment. She calls for a 10-year workforce plan to train and recruit enough specialists to meet rising demand. Without proper resourcing, she warns, the government’s promises to improve cancer care will fall flat.
NHS England, meanwhile, highlights its 5% growth in radiology and oncology workforces in 2024 and its commitment to transforming cancer care through the new national plan. However, they sidestepped the issue of hiring bans, focusing instead on supporting financially strained trusts and improving productivity.
So, what do you think? Are these hiring bans a necessary evil in the face of financial constraints, or a dangerous gamble with patients’ lives? Share your thoughts in the comments—let’s spark a conversation that could shape the future of cancer care in the UK.
